Skip to main content
Fig. 2 | BMC Medicine

Fig. 2

From: Beta-blocker efficacy across different cardiovascular indications: an umbrella review and meta-analytic assessment

Fig. 2

Representative heart failure meta-analyses for all-cause mortality.Most up-to-date and highest quality meta-analyses for heart failure. Results for other outcomes were similar to all-cause mortality. See Supplemental Figure 4 for full details. ACEi, angiotensin-converting enzyme inhibitors; ARB, angiotensin receptor blockers; bpm, beats/min; CKD, chronic kidney disease; HR, heart rate; LVEF, left ventricular ejection fraction

Back to article page

BMC Medicine

ISSN: 1741-7015

Contact us